Category: MS Drug Therapies

LONG-acting glatiramer acetate (GA) being investigated as a once-monthly injection for the treatment of relapsing forms of multiple sclerosis (RMS)

 NEWS PROVIDED BY Viatris Inc.   07 Aug, 2023 Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for…

Stuart Schlossman

Should We Use Lemtrada for MS in 2023? A Neurologist’s Perspective

  Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR  Visit the MS Views and News articles and videos…

Stuart Schlossman

Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab)

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Positive Results Announced from Phase 3 OCARINA II…

Stuart Schlossman

Review: Ocrevus best of 4 antibody therapies for progressive MS

 Drug found most effective also only one approved for PPMS by FDA by Steve Bryson, PhD | June 27, 2023 Among four antibody-based…

Stuart Schlossman

Mavenclad benefits for MS sustained up to 15 years after last treatment

 More than half who received it in clinical trials didn’t need further DMTs by Steve Bryson, PhD | April 11, 2023 The benefits…

Stuart Schlossman

Video: “BIOSIMILARS” – Learn ‘What is a Biosimilar medication’…

  Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube:…

Stuart Schlossman

video: Tips for accessing expensive MS medications on a limited budget – by Aaron Boster, MD

 Click to watch, then share with others Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit…

Stuart Schlossman

Tolebrutinib safely lowers relapse rates over 2.5 years

 Phase 2b extension trial now has 125 MS patients on 60 mg daily dose About 2.5 years of treatment with tolebrutinib was…

Stuart Schlossman

Early treatment could slow the onset of multiple sclerosis symptoms, study finds

 People with very early signs of MS who received the drug in a clinical trial were less likely to develop…

Stuart Schlossman

Interesting read: Learn about one of the newest MS medications – Tascenso-ODT (fingolimod)

  To learn about Tascenso-ODT which was just approved in February 2023,  click here Information provided by: Visit our MS…

Stuart Schlossman

Categories

Latest Blog Posts